Journey Medical Corp
Research Journey Medical Corp (DERM) on Bullrun: market cap USD 174.52M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerDERM
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- CurrencyUSD
- Market capUSD 174.52M
- Financial periodQ2 2026
- RevenueUSD 18.51M
- Net income-USD 312.00K
- Free cash flow-USD 1.73M
- Gross margin66.8%
Valuation Snapshot
latest market cap is USD 174.52M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 61.24M | -USD 11.43M | -USD 12.44M | 65.8% | -0.47 | USD 24.09M | USD 25.28M | USD 31.85M |
| FY2024 | USD 55.13M | -USD 14.67M | -USD 24.13M | 62.1% | -0.72 | USD 20.31M | USD 24.88M | USD 20.07M |
| FY2023 | USD 59.66M | -USD 3.85M | USD 240.00K | 61.6% | -0.21 | USD 27.44M | USD 14.62M | USD 20.35M |
| FY2022 | USD 71.00M | -USD 29.63M | -USD 33.53M | 56.7% | -1.69 | USD 32.00M | USD 19.83M | USD 16.98M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-09 | USD 174.52M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 209.29M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 86.62M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 106.61M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 34.11M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 93.16M | n/a | n/a | n/a |
About Journey Medical Corp
Journey Medical Corporation, a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Journey Medical Corp's market cap?
Journey Medical Corp's market capitalization is USD 174.52M.
What does Journey Medical Corp do?
Journey Medical Corporation, a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; and Amzeeq, a topical formulation of minocycline for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris.